On 30 June 2025, the BRAV∃ project concluded after 66 months of research and innovation.

PNO Innovation Spain, Portugal and Italy proudly acted as Leaders of Exploitation and Commercialisation activities.

The project developed a regenerative, personalized BioVAD (biological ventricular assist device) to support patients with ischemic heart disease.

By combining computational modeling, 3D printing and regenerative medicine, BRAV∃ achieved a major step forward in cardiovascular treatments.

Visit the project https://projectbrave.eu/ and follow @brav3_eu on X to learn more.

Contacts at PNO Innovation: Francesco Sottile (francesco.sottile@pnoinnovation.com) (and Mariana Cerqueira : mariana.cerqueira@pnoinnovation.com)